Free Trial

Benitec Biopharma (BNTC) SEC Filings & 10K Form

Benitec Biopharma logo
$13.24 +0.21 (+1.61%)
Closing price 08/29/2025 04:00 PM Eastern
Extended Trading
$13.64 +0.40 (+3.06%)
As of 08/29/2025 05:16 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Benitec Biopharma SEC Filings

DateFilerForm TypeView
08/14/2025
11:23 AM
Benitec Biopharma (Subject)
JANUS HENDERSON GROUP PLC (Filed by)
Form SCHEDULE 13G/A
08/14/2025
10:45 AM
Benitec Biopharma (Subject)
JANUS HENDERSON GROUP PLC (Filed by)
Form SCHEDULE 13G/A
06/02/2025
11:15 PM
Benitec Biopharma (Filer)
Form EFFECT
06/02/2025
4:04 PM
Benitec Biopharma (Filer)
Form 424B3
05/23/2025
3:32 PM
Benitec Biopharma (Filer)
Form S-3
Registration statement under Securities Act of 1933  
05/15/2025
3:38 PM
Benitec Biopharma (Subject)
Nantahala Capital Management, LLC (Filed by)
Form SCHEDULE 13G/A
05/14/2025
11:49 AM
Benitec Biopharma (Subject)
JANUS HENDERSON GROUP PLC (Filed by)
Form SCHEDULE 13G/A
05/14/2025
7:00 AM
Benitec Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/14/2025
6:09 AM
Benitec Biopharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/09/2025
12:06 PM
Benitec Biopharma (Subject)
FRANKLIN RESOURCES INC (Filed by)
Form SCHEDULE 13G/A
04/02/2025
3:37 PM
Averill Madison Master Fund, Ltd. (Reporting)
Averill Master Fund, Ltd. (Reporting)
Benitec Biopharma (Issuer)
Cowen Aaron (Reporting)
SUVRETTA CAPITAL MANAGEMENT, LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/28/2025
3:50 PM
Benitec Biopharma (Subject)
SUVRETTA CAPITAL MANAGEMENT, LLC (Filed by)
Form SCHEDULE 13D/A
03/28/2025
3:51 PM
Averill Madison Master Fund, Ltd. (Reporting)
Averill Master Fund, Ltd. (Reporting)
Benitec Biopharma (Issuer)
Cowen Aaron (Reporting)
SUVRETTA CAPITAL MANAGEMENT, LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/27/2025
4:10 PM
Benitec Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/26/2025
9:53 AM
Benitec Biopharma (Filer)
Form 424B5
03/26/2025
7:13 AM
Benitec Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/20/2025
4:25 PM
Benitec Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/19/2025
6:18 AM
Benitec Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/13/2025
3:43 PM
Benitec Biopharma (Issuer)
BUCHI J KEVIN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/03/2025
1:20 PM
Benitec Biopharma (Issuer)
BUCHI J KEVIN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2025
11:37 AM
Benitec Biopharma (Subject)
JANUS HENDERSON GROUP PLC (Filed by)
Form SCHEDULE 13G/A
02/14/2025
7:19 AM
Benitec Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2025
6:51 AM
Benitec Biopharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
02/13/2025
3:15 PM
Benitec Biopharma (Subject)
HBM Healthcare Investments Ltd. (0001232258) (Filed by)
Form SCHEDULE 13G/A
01/27/2025
11:51 AM
Benitec Biopharma (Subject)
FRANKLIN RESOURCES INC (Filed by)
Form SCHEDULE 13G/A
01/03/2025
4:39 PM
Benitec Biopharma (Issuer)
Mukadam Sophie (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
12/31/2024
5:34 AM
Benitec Biopharma (Filer)
Form 8-K/A
12/26/2024
3:28 PM
Averill Madison Master Fund, Ltd. (Reporting)
Averill Master Fund, Ltd. (Reporting)
Benitec Biopharma (Issuer)
Cowen Aaron (Reporting)
SUVRETTA CAPITAL MANAGEMENT, LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/13/2024
3:15 PM
Benitec Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/11/2024
5:48 PM
Benitec Biopharma (Issuer)
Mehta Kishan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/11/2024
4:17 PM
Benitec Biopharma (Issuer)
Boston Megan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/11/2024
4:19 PM
Banks Jerel A. (Reporting)
Benitec Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/11/2024
4:20 PM
Benitec Biopharma (Issuer)
Smith Edward F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/11/2024
4:22 PM
Benitec Biopharma (Issuer)
BUCHI J KEVIN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/11/2024
4:24 PM
Benitec Biopharma (Issuer)
Francis Peter (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/06/2024
4:01 PM
Benitec Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/06/2024
12:47 PM
Benitec Biopharma (Subject)
JANUS HENDERSON GROUP PLC (Filed by)
Form SC 13G/A
12/05/2024
3:36 PM
Averill Madison Master Fund, Ltd. (Reporting)
Averill Master Fund, Ltd. (Reporting)
Benitec Biopharma (Issuer)
Cowen Aaron (Reporting)
SUVRETTA CAPITAL MANAGEMENT, LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/18/2024
3:36 PM
Benitec Biopharma (Subject)
SUVRETTA CAPITAL MANAGEMENT, LLC (Filed by)
Form SC 13D/A
11/14/2024
3:53 PM
Benitec Biopharma (Subject)
Nantahala Capital Management, LLC (Filed by)
Form SCHEDULE 13G
11/14/2024
3:32 PM
Benitec Biopharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
What Steve Bannon revealed about Trump’s gold play (Ad)

A Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your IRA could be at risk. Here’s how to prepare.tc pixel

Download the Free Gold Protection Guide to get started now
11/12/2024
11:15 PM
Benitec Biopharma (Filer)
Form EFFECT
11/07/2024
11:30 AM
Benitec Biopharma (Subject)
FRANKLIN RESOURCES INC (Filed by)
Form SCHEDULE 13G/A
11/06/2024
2:26 PM
Benitec Biopharma (Subject)
JANUS HENDERSON GROUP PLC (Filed by)
Form SC 13G/A
11/01/2024
4:04 PM
Benitec Biopharma (Filer)
Form S-3
Registration statement under Securities Act of 1933  
10/25/2024
1:19 PM
Benitec Biopharma (Subject)
JANUS HENDERSON GROUP PLC (Filed by)
Form SC 13G/A
10/23/2024
8:23 AM
Benitec Biopharma (Filer)
Form DEF 14A
10/22/2024
4:24 PM
Benitec Biopharma (Filer)
Form DEFA14A
10/15/2024
7:07 AM
Benitec Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/15/2024
5:08 AM
Benitec Biopharma (Filer)
Form 424B5
10/11/2024
4:13 PM
Benitec Biopharma (Filer)
Form 424B5
10/11/2024
3:52 PM
Benitec Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/11/2024
3:53 PM
Benitec Biopharma (Filer)
Form PRE 14A
10/08/2024
3:45 PM
Benitec Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/01/2024
3:46 PM
Benitec Biopharma (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
09/30/2024
4:17 PM
Averill Madison Master Fund, Ltd. (Reporting)
Averill Master Fund, Ltd. (Reporting)
Benitec Biopharma (Issuer)
Cowen Aaron (Reporting)
SUVRETTA CAPITAL MANAGEMENT, LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/30/2024
4:18 PM
Benitec Biopharma (Subject)
SUVRETTA CAPITAL MANAGEMENT, LLC (Filed by)
Form SC 13D/A
09/26/2024
3:30 PM
Benitec Biopharma (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
09/26/2024
3:43 PM
Benitec Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:BNTC) was last updated on 8/31/2025 by MarketBeat.com Staff
From Our Partners